Neuroelectrics

www.neuroelectrics.com ↗ ·Barcelona ·Series A

Neuroelectrics is a Barcelona-based digital brain health company, with a US office in Cambridge, Massachusetts. It develops non-invasive brain monitoring and stimulation technology, including the Enobio wireless EEG and Starstim transcranial current stimulation (tDCS/tACS/tRNS) systems. It pairs these devices with software, modelling and research services for personalised neuromodulation. Its customers are research institutions and clinicians, and it is running clinical programmes in drug-resistant epilepsy and major depressive disorder. The epilepsy programme has received FDA Breakthrough Device Designation, and a cloud-based platform lets patients receive treatment at home. The company was founded in 2011 by Ana Maiques and Giulio Ruffini as a spin-off of Starlab. In 2021 it raised a $17.5M Series A led by Morningside Ventures.

Founded

2011

Founders

Total funds raised

$17.5M

SectorsMedtech, Neurotechnology, Digital Health, Medical Devices Start-up MapHealthtech & Bio › Medical devices & surgical hardware

Suggest a correction

Founders

Ana Maiques

Co-founder & CEO

Also at Zubi Capital →

Giulio Ruffini

Co-founder & Chief Science Officer

Global models 4

Cognito Therapeutics

United States · www.cognitotx.com ↗

Develops a non-invasive neurostimulation device (gamma sensory stimulation) as a clinical-stage therapy for Alzheimer's disease, the same device-plus-clinical-trials path as Neuroelectrics' epilepsy and depression programmes.

$250MComparable

Ceribell

United States · ceribell.com ↗

Sells non-invasive EEG brain-monitoring hardware with AI software to hospitals and clinicians, like Neuroelectrics' Enobio EEG business (VC total is before its 2024 IPO).

$200MComparable

Kernel

United States · www.kernel.com ↗

Makes non-invasive brain-monitoring headsets and analytics sold to research institutions and pharma, like Neuroelectrics' research-device line.

$107MComparable

Flow Neuroscience

Sweden · flowneuroscience.com ↗

Sells a home tDCS brain-stimulation headset with a software app for treating depression, the same non-invasive stimulation approach Neuroelectrics uses in its depression programme.

$30MComparable

In the same niche 72 others

See all in the Start-ups Map →

Anaconda Biomed

Sant Cugat del Vallès

Series C · €90.1M

INBRAIN Neuroelectronics

Venture Debt · €71.2M

Medlumics

Madrid

No stage disclosed · €57.8M

+66 more →

Notes: Most funded first

Investors 2

Open as list →

Intelectium

www.intelectium.com

Investor Spain

Morningside Ventures

www.morningside.com ↗

Led Series A 2021 United States

Funding rounds 1

Date	Round	Amount	Lead
2021-05-04	Series A	$17.5M	Morningside Ventures

News 6

Open as list →

Published	Article
2026-10-02	VDS 2026 anuncia su agenda: más de 600 ponentes y 17 unicornios se darán cita en Valencia ↗ El Español 2026-10-02
2026-03-19	The EU-Startups Podcast \| Interview with Ana Maiques, CEO and co-founder of Neuroelectrics ↗ EU-Startups 2026-03-19
2024-12-06	AI in Neuroscience: Neuroelectrics and the Future of Brain Health ↗ AI for Good (ITU) 2024-12-06
2024-09-28	Esta emprendedora factura 5,5 millones con un casco de estimulación que trata la depresión o el Alzheimer ↗ Diario Autónomos y Emprendedor 2024-09-28
2024-06-14	Brain science start-up Neuroelectrics uses electricity and a headcap to reduce seizures in patients with epilepsy. Now it needs FDA approval ↗ CNBC 2024-06-14
2024-03-07	Neuroelectrics Announces Results of Telemedicine Pilot Depression Study with Starstim tDCS Therapy ↗ Business Wire 2024-03-07